Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


High Court agrees to assess pharmacy funding cuts next year

The High Court has given the Pharmaceutical Services Negotiating Committee (PSNC) permission for a judicial review of the pharmacy funding cuts, the negotiator has confirmed.

The hearing is scheduled for the second week of February, PSNC said.

However, the judge “has indicated” that if the government asks for a later hearing date, then “the question will arise of whether there should be a delay in the implementation of [the funding cuts] while the case is ongoing”, PSNC added.

The negotiator announced earlier this month that it had sought a judicial review, on the grounds that the Secretary of State “failed to carry out a lawful consultation” on the proposals for the sector.

Two weeks later, the National Pharmacy Association announced that it is also planning to take its legal challenge against the cuts to the High Court.

Read C+D’s exclusive interview with PSNC chief executive Sue Sharpe – where she explains why its legal challenge shows it has reached the “end of the road” with the Department of Health – here.

How will the funding cuts affect you?

Related Content


Pharmacy Manager
Newquay, Cornwall
£ Competitive

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts